Gerresheimer, DE000A0LD6E6

Gerresheimer reports EcoVadis Gold. Gerresheimer stock sits 0.70 percent below its high

Published on 10/21/2026 at 10:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
EcoVadis lifted Gerresheimer's score to 82 of 100 points on October 14, 2026. Gerresheimer stock costs EUR 32.66 on October 21, 2026, 0.31 percent below the Xetra close.

Operational and sustainability markers

  • Gerresheimer raised its EcoVadis score to 82 out of 100 points on October 14, 2026.
  • Adjusted EBITDA reached EUR 102 million in the second quarter of 2026, according to the September 30, 2026 report.
  • Gerresheimer stock trades at EUR 32.66 at 10:15 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.31 percent below the Xetra close of October 20, 2026.
  • The final first-half 2026 report is scheduled for November 2026.
Gerresheimer AG mit ISIN DE000A0LD6E6 produziert Glasampullen in hochautomatisierter, steriler Pharmaverpackungsfertigung mit modernster Anlagentechnik, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) had raised its EcoVadis score from 78 in 2025 to 82 out of 100 points on October 14, 2026, earning another Gold rating, according to MarketScreener. Gerresheimer stock sits 0.70 percent below its 52-week high of EUR 32.89.

Gold rating adds a fresh marker

The sustainability result is the latest dated company event, but the investment case still turns on operating recovery. EcoVadis placed Gerresheimer among the top 5 percent of rated companies and within the top 2 percent of its industry, while sustainable procurement ranked in the top 1 percent, MarketScreener reported on October 14, 2026.

What changed in the second quarter?

Gerresheimer's preliminary second-quarter 2026 revenue reached EUR 578 million, down from EUR 614 million in the year-earlier quarter. Adjusted EBITDA rose to EUR 102 million from EUR 67 million in the first quarter, an increase of EUR 35 million, and the adjusted EBITDA margin reached 17.6 percent. These figures came from the company's September 30, 2026 release, published by Gerresheimer.

Three dates define the turnaround

On September 30, 2026, Gerresheimer reported second-quarter revenue of EUR 578 million and adjusted EBITDA of EUR 102 million. On October 1, 2026, it completed the Centor sale, with a combined enterprise value of EUR 1.5 billion for Centor and the Primary Packaging Plastics business, according to Goldesel. On October 14, 2026, the EcoVadis score reached 82 points, as MarketScreener reported.

When are the next results due?

Gerresheimer's final first-half 2026 report is scheduled for November 2026, followed by the third-quarter statement in December 2026, according to the company's investor calendar and the September 30, 2026 release published by EQS News. The timing leaves the second-half recovery and debt reduction after the portfolio sales as the next measurable tests.

Stock trades below its yearly high

Gerresheimer stock was trading at EUR 32.66 at Lang & Schwarz on October 21, 2026 at 10:15 a.m. CEST, down EUR 0.10, or 0.31 percent, versus the Xetra close of October 20, 2026 at EUR 32.76. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.

Gerresheimer stock facts

  • Company: Gerresheimer AG
  • ISIN: DE000A0LD6E6
  • WKN: A0LD6E
  • Ticker: GXI.DE
  • Primary exchange: Xetra
  • Price Lang & Schwarz as of October 21, 2026, 10:15 a.m. CEST: EUR 32.66
  • Change versus Xetra close: minus 0.31 percent
  • Xetra close October 20, 2026: EUR 32.76
  • Market capitalization: EUR 1.1 billion as of October 21, 2026
  • 52-week range: EUR 14.83-EUR 32.89 as of October 21, 2026
  • Sector / Industry: Healthcare / Medical Equipment, Supplies and Distribution

Market context: Market report DAX.

More news and analyses on Gerresheimer stock

Disclaimer...
en | DE000A0LD6E6 | GERRESHEIMER | boerse | 70381427 | bgmi